Processa Pharmaceuticals (NASDAQ:PCSA) Shares Down 0.6% – Here’s What Happened

Shares of Processa Pharmaceuticals, Inc. (NASDAQ:PCSA) dropped 0.6% during mid-day trading on Thursday . The stock traded as low as $0.80 and last traded at $0.87. Approximately 82,238 shares traded hands during trading, an increase of 27% from the average daily volume of 64,574 shares. The stock had previously closed at $0.87.

Analyst Ratings Changes

Separately, HC Wainwright reiterated a “buy” rating and issued a $6.00 target price on shares of Processa Pharmaceuticals in a report on Thursday, December 5th.

Processa Pharmaceuticals Price Performance

The firm has a market capitalization of $2.64 million, a PE ratio of -0.24 and a beta of 0.62. The stock has a 50-day moving average price of $0.98 and a 200-day moving average price of $1.30.

Processa Pharmaceuticals Company Profile

Processa Pharmaceuticals, Inc, a clinical stage biopharmaceutical company, develops chemotherapy drugs to improve the safety and efficacy of cancer treatment. Its drugs are modifications of existing FDA-approved oncology drugs resulting in an alteration of the metabolism and/or distribution of drugs while maintaining the existing mechanisms of killing the cancer cells.